# Delaware Chancery keeps $8.9 billion R1 RCM buyout stockholder claim alive

Attorney advertising. Brief by Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. Published 2026-10-28; updated 2026-10-28. Responsible attorney: Lou Schwartz. Canonical: https://www.snalawyers.com/insights/delaware-chancery-keeps-8-9-billion-r1-rcm-buyout-stockholder-claim-al

Vice Chancellor J. Travis Laster denied a motion to dismiss Count I of a consolidated stockholder suit challenging R1 RCM Inc.'s $8.9 billion take-private sale to TowerBrook Capital Partners LP and Ascension Health Alliance. The court found that the private equity firm and health system's joint investment vehicle could qualify as a controlling stockholder for fiduciary-duty purposes even though it held less than one-third of R1 RCM's voting shares, allowing the stockholder claim challenging the deal to proceed past the pleading stage.

**Why it matters.** The ruling signals Delaware courts' willingness to find controlling-stockholder status based on influence rather than raw voting percentage, a theory relevant to shareholders challenging other minority-stake buyouts led by private equity and strategic co-investors.

## Sources

1. [Law360](https://www.law360.com/health/articles/2543980)
2. [CourtListener opinion](https://www.courtlistener.com/opinion/11048256/in-re-r1-rcm-inc-merger-litigation/)

To ask the firm about this, use the intake assistant at https://www.snalawyers.com/insights/delaware-chancery-keeps-8-9-billion-r1-rcm-buyout-stockholder-claim-al#ask. General information, not legal advice.
